MICHAEL ROGGELIN: Open Payments
NPI 1528520756 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,530 in 98 payments from 12 companies in 2025. Trend: 2023 $2,360 · 2024 $9,467 · 2025 $5,530
Speaker / faculty: $3,000Food & beverage: $2,232Travel & lodging: $298
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 51 | $4,446 |
| Gilead Sciences, Inc. | 25 | $607 |
| Merck Sharp & Dohme LLC | 8 | $160 |
| Theratechnologies Inc. | 5 | $126 |
| Verity Pharmaceuticals Inc. | 1 | $34 |
| ABBVIE INC. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| TOLMAR, INC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: APRETUDE, CABENUVA, DOVATO, EGRIFTA, PIFELTRO, RUKOBIA, Biktarvy, GARDASIL 9.
Industry payments across FL — which companies pay providers there.
